How much revenue does the coronary artery bypass graft market generate?

The market valuation of the coronary artery bypass graft is USD 22.31 billion in 2027.

What is the forecasted size of the coronary artery bypass graft industry?

Coronary Artery Bypass Graft Market size stood at USD 21.7 billion in 2026 and is predicted to grow at a 3.33% CAGR from 2027 to 2036, reaching USD 30.11 billion by 2036.

How is the rising prevalence of complex coronary artery disease influencing demand in the coronary artery bypass graft market?

Growing numbers of patients with multivessel disease, left main disease, and recurrent symptoms are increasing referrals for surgical revascularization, driving demand for bypass procedures, surgical planning technologies, and associated operative care.

Why are hospitals increasing investment in cardiac surgical capabilities for coronary bypass procedures?

Rising cardiovascular care demand is prompting hospitals to expand hybrid operating rooms, perfusion systems, imaging, intensive care infrastructure, and specialized cardiac teams, improving procedural readiness and strengthening in-house cardiac service capacity.

Why does the On-pump method lead the coronary artery bypass graft market?

On-pump held a 64.66% market share in 2026 due to its ability to provide surgical stability and controlled operating conditions, making it the preferred approach for complex grafting procedures requiring precision and consistency.

Which surgical procedure segment is growing the fastest in the coronary artery bypass graft market?

Double Bypass is the fastest-growing procedure segment, gaining traction because it suits patients requiring treatment of two affected coronary vessels while supporting a more targeted revascularization approach.

Why does North America lead the coronary artery bypass graft market?

North America leads due to high surgical volumes, strong cardiac care networks, skilled surgeons, and established referral systems managing complex coronary artery disease cases.

What is driving growth in Asia Pacific’s coronary artery bypass graft market?

Asia Pacific is expanding at 10.85% CAGR, driven by improving cardiac surgery access, rising cardiovascular disease burden, and expanding hospital capacity for complex procedures.

What are the prominent companies operating in the coronary artery bypass graft landscape?

Key players in the coronary artery bypass graft market include Medtronic plc (Ireland), Terumo Corporation (Japan), Getinge AB (Sweden), W. L. Gore & Associates Inc. (United States), B. Braun SE (Germany), Abbott Laboratories (United States), LivaNova plc (United Kingdom), Edwards Lifesciences Corporation (United States), Baxter International Inc. (United States), Teleflex Incorporated (United States).